U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for acute heart failure, this patent would provide protection to ...

NEW CANAAN, CT / ACCESS Newswire / June 30, 2025 / Network-1 T, Inc. (NYSE:NTIP) announced today that it has initiated patent ...

Patent deals are getting done. Although the value of the patent deals currently being consummated has not increased in 2025 ...

Earlier today, a filing made by attorneys from both the U.S. Department of Justice, Antitrust Division, and the United States Patent & Trademark Office (USPTO) was filed that suggests that the court ...

America's patent system should not give deep-pocketed infringers multiple chances in different forums to invalidate patents.

1.3 million patients are hospitalized annually in the U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for ...

A federal jury in Delaware found that Apple's devices infringe on a patent related to 3G wireless communications.

Acute heart failure, or AHF, impacts millions of patients globally and istaroxime has previously completed two positive Phase 2 AHF studies and two positive early cardiogenic shock studies caused by ...

Jeremy Saks and Benjamin C. Elacqua of Fish & Richardson PC discuss obtaining general exclusion orders at the International ...

Senzime’s neuromuscular monitoring solution, TetraGraph system receives US patent: Uppsala, Sweden Thursday, July 3, 2025, 16:00 Hrs [IST] Uppsala-headquartered Senzime, a leadi ...